But Amox is not considered a "New technology", as a poster here suggested. See the difference?
I'm sure. I think UCLA has done the same for their version. "Increments".
>>DCVax-l purity, release standards and quality control have been improved over the last decade.
Maybe but a goal post move for investors.
>>The DCVax-l formulation that includes poly-iclc appears to be the superior option for some subtypes. Adding CI to these appears to increase survival further in rGBM.
Future combinations including plx-3395 will likely increase efficacy several fold.
When you can see the complete data on L's Plll let me know, Doctor Flipper.
>>Your idea of virus therapy or sonic therapy seems knee jerk, unscientific and a distraction.
Market Data 
Markets 
AI
